Liu B, Chen J, Chen L, Chen X, et al. Efficacy and safety of cadonilimab combined with chemotherapy as first-line
treatment for primary advanced or recurrent endometrial cancer: An interim
analysis of a prospective, single-arm, open-label phase II trial. Gynecol Oncol 2026;207S:14-22.
PMID: 42000370
|